Assessment of the Efficacy and Safety of Pembrolizumab for Ovarian Squamous Cell Carcinoma
Clinical trial NCT05737199 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05737199
- Sponsor
- Niigata University Medical & Dental Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2028-05-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.